300 related articles for article (PubMed ID: 28698380)
1. MmpL3 is the flippase for mycolic acids in mycobacteria.
Xu Z; Meshcheryakov VA; Poce G; Chng SS
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):7993-7998. PubMed ID: 28698380
[TBL] [Abstract][Full Text] [Related]
2. A piperidinol-containing molecule is active against
Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
[No Abstract] [Full Text] [Related]
3. MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine.
Su CC; Klenotic PA; Bolla JR; Purdy GE; Robinson CV; Yu EW
Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11241-11246. PubMed ID: 31113875
[TBL] [Abstract][Full Text] [Related]
4. Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria.
Fay A; Czudnochowski N; Rock JM; Johnson JR; Krogan NJ; Rosenberg O; Glickman MS
mBio; 2019 Jun; 10(3):. PubMed ID: 31239378
[TBL] [Abstract][Full Text] [Related]
5. Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis.
Li W; Upadhyay A; Fontes FL; North EJ; Wang Y; Crans DC; Grzegorzewicz AE; Jones V; Franzblau SG; Lee RE; Crick DC; Jackson M
Antimicrob Agents Chemother; 2014 Nov; 58(11):6413-23. PubMed ID: 25136022
[TBL] [Abstract][Full Text] [Related]
6. MmpL3 inhibitors as antituberculosis drugs.
Shao M; McNeil M; Cook GM; Lu X
Eur J Med Chem; 2020 Aug; 200():112390. PubMed ID: 32447196
[TBL] [Abstract][Full Text] [Related]
7. Structures of the mycobacterial membrane protein MmpL3 reveal its mechanism of lipid transport.
Su CC; Klenotic PA; Cui M; Lyu M; Morgan CE; Yu EW
PLoS Biol; 2021 Aug; 19(8):e3001370. PubMed ID: 34383749
[TBL] [Abstract][Full Text] [Related]
8. Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.
Belardinelli JM; Yazidi A; Yang L; Fabre L; Li W; Jacques B; Angala SK; Rouiller I; Zgurskaya HI; Sygusch J; Jackson M
ACS Infect Dis; 2016 Oct; 2(10):702-713. PubMed ID: 27737557
[TBL] [Abstract][Full Text] [Related]
9. Targeting MmpL3 for anti-tuberculosis drug development.
Bolla JR
Biochem Soc Trans; 2020 Aug; 48(4):1463-1472. PubMed ID: 32662825
[TBL] [Abstract][Full Text] [Related]
10. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.
Tahlan K; Wilson R; Kastrinsky DB; Arora K; Nair V; Fischer E; Barnes SW; Walker JR; Alland D; Barry CE; Boshoff HI
Antimicrob Agents Chemother; 2012 Apr; 56(4):1797-809. PubMed ID: 22252828
[TBL] [Abstract][Full Text] [Related]
11. 1
Korycka-Machała M; Viljoen A; Pawełczyk J; Borówka P; Dziadek B; Gobis K; Brzostek A; Kawka M; Blaise M; Strapagiel D; Kremer L; Dziadek J
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332069
[TBL] [Abstract][Full Text] [Related]
12. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of anti-mycobacterial drug leads that target the mycolic acid transporter MmpL3.
Hu T; Yang X; Liu F; Sun S; Xiong Z; Liang J; Yang X; Wang H; Yang X; Guddat LW; Yang H; Rao Z; Zhang B
Structure; 2022 Oct; 30(10):1395-1402.e4. PubMed ID: 35981536
[TBL] [Abstract][Full Text] [Related]
14. Acetylation of trehalose mycolates is required for efficient MmpL-mediated membrane transport in Corynebacterineae.
Yamaryo-Botte Y; Rainczuk AK; Lea-Smith DJ; Brammananth R; van der Peet PL; Meikle P; Ralton JE; Rupasinghe TW; Williams SJ; Coppel RL; Crellin PK; McConville MJ
ACS Chem Biol; 2015 Mar; 10(3):734-46. PubMed ID: 25427102
[TBL] [Abstract][Full Text] [Related]
15. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.
La Rosa V; Poce G; Canseco JO; Buroni S; Pasca MR; Biava M; Raju RM; Porretta GC; Alfonso S; Battilocchio C; Javid B; Sorrentino F; Ioerger TR; Sacchettini JC; Manetti F; Botta M; De Logu A; Rubin EJ; De Rossi E
Antimicrob Agents Chemother; 2012 Jan; 56(1):324-31. PubMed ID: 22024828
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional evidence that lipoprotein LpqN supports cell envelope biogenesis in
Melly GC; Stokas H; Dunaj JL; Hsu FF; Rajavel M; Su CC; Yu EW; Purdy GE
J Biol Chem; 2019 Oct; 294(43):15711-15723. PubMed ID: 31471317
[TBL] [Abstract][Full Text] [Related]
17. Molecular Modelling and Atomistic Insights into the Binding Mechanism of MmpL3 Mtb.
Kwofie SK; Hanson G; Sasu H; Enninful KS; Mensah FA; Nortey RT; Yeboah OP; Agoni C; Wilson MD
Chem Biodivers; 2022 Sep; 19(9):e202200160. PubMed ID: 35969844
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of the mycobacterial trehalose monomycolate transport factor A, TtfA, reveals an atypical fold.
Ung KL; Alsarraf HMAB; Kremer L; Blaise M
Proteins; 2020 Jun; 88(6):809-815. PubMed ID: 31833106
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane.
Grzegorzewicz AE; Pham H; Gundi VA; Scherman MS; North EJ; Hess T; Jones V; Gruppo V; Born SE; Korduláková J; Chavadi SS; Morisseau C; Lenaerts AJ; Lee RE; McNeil MR; Jackson M
Nat Chem Biol; 2012 Feb; 8(4):334-41. PubMed ID: 22344175
[TBL] [Abstract][Full Text] [Related]
20. MmpL11 protein transports mycolic acid-containing lipids to the mycobacterial cell wall and contributes to biofilm formation in Mycobacterium smegmatis.
Pacheco SA; Hsu FF; Powers KM; Purdy GE
J Biol Chem; 2013 Aug; 288(33):24213-22. PubMed ID: 23836904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
